Henry Schein Archives - Page 4 of 5 - Medical Design Sourcing

World Health Organization sending 36 metric tons of medical supplies to Ukraine

Photo by Yehor Milohrodskyi on Unsplash

The World Health Organization today said that it is sending more than 36 metric tons of medical supplies to support the humanitarian emergency in Ukraine following Russia’s invasion last week.

WHO Director-General Tedros Adhanom Ghebreyesus said the organization is sending “essential medical supplies” to Ukraine — including its first shipment of 36 metric tons of supplies for trauma care and emergency surgery and other health supplies — to meet the needs of more than 150,000 patients.

“Prior to the conflict, WHO distributed emergency supplies to 23 hospitals, although our prepositioned supplies in Kyiv are currently inaccessible,” Ghebreyesus said in a press briefing. “There is an urgent need to establish a corridor to ensure humanitarian workers and supplies have safe and continuous access to reach people in need.”

Get the full story on our sister site, Medical Design & Outsourcing.

World Health Organization sending 36 metric tons of medical supplies to Ukraine

Photo by Yehor Milohrodskyi on Unsplash

The World Health Organization today said that it is sending more than 36 metric tons of medical supplies to support the humanitarian emergency in Ukraine following Russia’s invasion last week.

WHO Director-General Tedros Adhanom Ghebreyesus said the organization is sending “essential medical supplies” to Ukraine — including its first shipment of 36 metric tons of supplies for trauma care and emergency surgery and other health supplies — to meet the needs of more than 150,000 patients.

“Prior to the conflict, WHO distributed emergency supplies to 23 hospitals, although our prepositioned supplies in Kyiv are currently inaccessible,” Ghebreyesus said in a press briefing. “There is an urgent need to establish a corridor to ensure humanitarian workers and supplies have safe and continuous access to reach people in need.”

…

Henry Schein rises before hours on Street-beating Q4, updated guidance

Henry Schein (NSDQ:HSIC) shares ticked up this morning on fourth-quarter results that topped the consensus forecast.

The Melville, New York-based company posted profits of $147.2 million, or $1.05 per share, on sales of $3.3 billion for the three months ended Dec. 25, 2021, for a 3.2% bottom-line gain on sales growth of 5.2%.

Adjusted to exclude one-time items, earnings per share were $1.07, 16¢ ahead of Wall Street, where analysts were looking for sales of $3.1 billion.

Henry Schein’s dental sales increased by 9.4% year-over-year, although the company’s $1.1 billion in medical sales represented a 3.2% dip from 2021. Excluding sales of personal protective equipment (PPE) and COVID-19-related products, sales increased by 3.6%, as PPE and COVID-19-related products were in higher demand this time last year, according to a news release.

“Despite the impact of the global COVID-19 pandemic, we are pleased to report excellent full-year 2021 f…

Henry Schein CFO is retiring, replacement named

Henry Schein today announced its chief financial officer Steven Paladino will retire later this year and that Ronald South will replace him.

Paladino’s is set to retire on April 29 after 35 years with the Melville, N.Y.-based dental supplier. He will remain a member of the board of directors and will become an adviser to Henry Schein after his retirement.

“After an impressive 35 years of distinguished service to Henry Schein, Steven has decided to spend more time with his family,” CEO Stanley Bergman said in a news release. “We are pleased that Steven will remain on the board of Henry Schein and as an adviser following his retirement. On behalf of the board of directors and team Schein, I would like to thank Steven for his leadership and significant contributions to the Company. The depth and breadth of Steven’s skills and his long-standing relationships with the financial community have been central to the development and execution of our business strate…

Former Blue Cross Blue Shield CEO joins Henry Schein board of directors

Henry Schein (Nasdaq: HSIC) announced today that it appointed Scott Serota as a member of its board of directors.

Melville, N.Y.-based Henry Schein said in a news release that Serota will serve until the 2022 annual meeting of stockholders in May, at which point he is expected to stand for re-election to the board by a vote of the company’s stockholders.

In addition to his appointment to the board, Serota was appointed as a member of the board’s strategic advisory committee. Barry Alperin is set to retire from the board in May as well.

“Barry was instrumental in helping to guide Henry Schein through a period of accelerated growth, beginning shortly after our initial public offering in 1995,” Henry Schein Chairman & CEO Stanley M. Bergman said in the release. “He contributed significantly to our success, serving the company with distinction and providing counsel on matters such as strategic planning, governance, and executive compensation.…

Baxter, 3M, Abbott near the top of Newsweeks’ most reponsible companies list

Several medtech, healthcare and life sciences companies, including big names like Abbott (NYSE:ABT), 3M (NYSE:MMM) and Baxter (NYSE:BAX), are among the 500 “most responsible,” according to Newsweek.

The outlet published its “America’s Most Responsible Companies 2022” list, marking the third installment of the compilation (in partnership with Statista), this time expanded to include 500 of the largest public corporations around. Companies were judged with an overall score out of 100 that combined environmental, social and corporate governance performance assessments.

Baxter, 3M, Abbott and BD (NYSE:BDX) were among the highest-ranking big-name medical device makers. Cancer diagnostic company Illumina was the highest-ranking company under the healthcare and life sciences umbrella, sitting in second behind HP.

In sixth sat Baxter, registering an overall score of 89.5 points, with its highest performance coming in environmental i…

Henry Schein beats The Street in Q3, increases EPS projections

Henry Schein (NSDQ:HSIC) shares ticked up today on third-quarter results that beat the consensus forecast.

The Melville, New York-based company posted profits of $162.3 million, or $1.15 per share, on sales of $3.2 billion for the three months ended Sept. 25, 2021, for a 14.5% bottom-line gain on sales growth of 11.9%.

Adjusted to exclude one-time items, earnings per share were $1.10, 15¢ ahead of Wall Street, where analysts were looking for sales of $3 billion.

Henry Schein’s global medical sales came in at $1.2 billion, marking a 15.5% increase against the comparable period last year. Excluding COVID-19-related products and PPE, internal sales in local currencies increased 8.3%. The company noted positive trends in the physician office, ambulatory surgery center and alternate care markets.

“Today we reported record third-quarter financial results, driven by a keen focus on execution by team Schein and steady patient traffic, resulting in e…

Women researchers receive a fraction of funding from the world’s biggest medtech companies

The gender divide in medtech extends beyond leadership and into funding for investigational studies by U.S. physicians.

Only 6.7% of physicians who received research payments from the world’s largest medical device companies in 2020 were women, according to an analysis of Medical Design & Outsourcing’s Big 100 list of medtech companies and CMS Open Payments data.

Among the 20 medical device companies that fund research by U.S. physicians are 3M, Abbott, BD, Boston Scientific, Johnson & Johnson (dba J&J Surgical Vision and J&J Vision Care), Medtronic (dba Medtronic, Medtronic Minimed, Medtronic USA, Medtronic Vascular), Royal Philips (dba Philips Electronics), Stryker and Zimmer Biomet.

Together, those companies paid $3.9 million to 312 doctors in 2020, but only 21 were women, receiving a collective $402,600.

Women physicians, on average, received 15.7% of payments from each of the top medtech companies, but accounted f…

Henry Schein promotes top lawyers

Walter Siegel [Photo courtesy of Henry Schein]Henry Schein (Nasdaq: HSIC) has promoted four members of its legal team to high-ranking positions.

The medical device manufacturer and distributor on Monday named SVP Walter Siegel as chief legal officer, Kelly Murphy as SVP and general counsel, Jennifer Ferrero as deputy secretary and Reid Arstark to senior counsel, mergers & acquisitions.

Get the full story at our sister site, Medical Design & Outsourcing.

Henry Schein promotes top lawyers

Henry Schein (Nasdaq: HSIC) has promoted four members of its legal team to high-ranking positions.

Walter Siegel [Photo courtesy of Henry Schein]

The medical device manufacturer and distributor on Monday named SVP Walter Siegel as chief legal officer, Kelly Murphy as SVP and general counsel, Jennifer Ferrero as deputy secretary and Reid Arstark to senior counsel, mergers & acquisitions.

“Walter quickly distinguished himself throughout the Company with his integrity, legal acumen, strategic thinking, and leadership skills,” Henry Schein CEO and Board Chair Stanley Bergman said in a news release. “Walter’s new role reflects the increasing global complexity of the laws, rules, and regulations that multi-national companies must navigate. We are pleased to have Walter in this expanded role.”

Kelly Murphy [Photo courtesy of Henry Schein]

Sieg…

Henry Schein beats The Street in Q2 results, raises guidance

Henry Schein (NSDQ:HSIC) today posted second-quarter results that beat the overall consensus on Wall Street.

The Melville, N.Y.-based company reported profits of $163.9 million, or $1.10 per share, on sales of $2.9 billion for the three months ended June 26, for a sales growth of 76.2% compared with Q2 2020.

Adjusted to exclude one-time items, earnings per share were $1.11, 14¢ ahead of The Street, where analysts were looking for sales of $2.89 billion.

“We are pleased to report record second-quarter financial results as we continue to execute on our key strategies. Strengthening demand in the global dental and medical markets drove strong year-over-year increases in sales versus the prior year when many of our customers had temporarily closed their offices. Notably, compared with a pre-COVID-19 environment in the second quarter of 2019, Henry Schein’s worldwide internal sales in local currencies increased by 15.2%,” CEO Stanley Bergman said in a news re…

Midmark wants to make blood pressure readings more accurate: Here’s how

The Midmark IQvitals Zone allows caregivers to centralize vital signs acquisition at the point of care. [Image courtesy of Midmark]

Midmark (Dayton, Ohio) has added a Systolic Blood Pressure Intervention Trial (SPRINT) BP Protocol for its IQvitals Zone vital signs device.

The systolic blood pressure (BP) measurement protocol, based on the SPRINT trial conducted in 2015, is meant to enable better blood pressure readings through proper patient positioning and minimizing interruptions.

“The SPRINT BP Protocol is the next step in helping caregivers standardize accurate and consistent BP measurements at the point of care — and Midmark is the first company to implement a SPRINT protocol with patient positioning guidelines in a vital signs acquisition device to help ensure the protocol is being followed,” said Kurt Forsthoefel, marketing director of medical products and services at Midmark.

“When the SPR…